One giant leap for cephalexin dosing, one small step for antimicrobial stewardship

被引:0
作者
Chin, Paul Ken Leong [1 ,2 ]
Than, Martin [3 ]
Chambers, Stephen [4 ]
机构
[1] Univ Otago, Dept Med, Private Bag, Christchurch 4345, New Zealand
[2] Te Whatu Ora Hlth New Zealand, Dept Clin Pharmacol, Christchurch, Waitaha Canterb, New Zealand
[3] Christchurch Hosp, Emergency Dept, Christchurch, New Zealand
[4] Univ Otago, Dept Pathol, Christchurch, New Zealand
关键词
Cephalexin; Cellulitis; Emergency department; Pharmacokinetics;
D O I
10.1007/s43678-022-00442-6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:7 / 8
页数:2
相关论文
共 5 条
[1]   Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J].
Craig, WA .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) :1-10
[2]   Intravenous cefazolin plus oral probenecid versus oral cephalexin for the treatment of skin and soft tissue infections: a double-blind, non-inferiority, randomised controlled trial [J].
Dalen, Dawn ;
Fry, Amy ;
Campbell, Samuel G. ;
Eppler, Jeffrey ;
Zed, Peter J. .
EMERGENCY MEDICINE JOURNAL, 2018, 35 (08) :492-498
[3]   What is antimicrobial stewardship? [J].
Dyar, O. J. ;
Huttner, B. ;
Schouten, J. ;
Pulcini, C. .
CLINICAL MICROBIOLOGY AND INFECTION, 2017, 23 (11) :793-798
[4]   Probenecid effects on cephalexin pharmacokinetics and pharmacodynamics in healthy volunteers [J].
Everts, Richard J. ;
Gardiner, Sharon J. ;
Zhang, Mei ;
Begg, Ronald ;
Chambers, Stephen T. ;
Turnidge, John ;
Begg, Evan J. .
JOURNAL OF INFECTION, 2021, 83 (02) :182-189
[5]  
Yadav, 2022, HIGH DOSE CEPHALEXIN